I had wondered why the FDA approved the Alz. drug while NONE of the FDA neurology advisors voted for it
(3 advisors resigned in protest later that week).
“Follow the money”
Cost of drug that might slow the progression of Alzheimer's in an individual by 20% = $56,000/year
Assume that 1/3 of Alzheimer’s of the 6 million patients get the drug (2 million)
Cost of the drug to Medicare for 2 million people = $112 Billion
Kickbacks to doctors administering the drug = $6.7 Billion
Suspect
1) When that person at the FDA retires he will go to work for the drug company/AMA with a salary of over $2 million a year
2) UD Alzheimer doctors in the future may get more income than Chemo doctors
Note:
VitaminDWiki predicted that by 2024 Alzheimer’s and Parkinson’s patients will start to be treated by Vitamin D, Omega-3, etc – The dose size to be adjusted on an individual basis as has been the case for Multiple Sclerosis
Article which got me interested: The Drug That Could Break American Health Care The Atlantic
- FDA approves controversial Alzheimer’s drug aducanumab (Aduhelm) MDedge
- More than half of the FDA entire budget now comes from Big Pharma, not the govt. – Sept 2018
- Off topic – FDA buried evidence of fraud in 78 of 600 clinical trials – Feb 2014
- Off Topic: FDA advisors have many conflicts of interest
- After 57 years FDA is declaring NAC to be a drug (note: 16 trials are investigating NAC ability to fight COVID-19) – June 2021
- Off topic: Conflicts of Interest at the FDA - NYT April 2015
- US govt ==>lobbyist ==> Monsanto VP ==> FDA see wikipedia